X4 Pharmaceuticals Income Statement (2018-2025) | XFOR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.17M-0.17M-0.15M3.50M3.00M-0.91M-0.92M-1.02M-1.14M-1.11M0.56M0.56M1.48M28.81M1.97M1.76M
Gross Profit 0.29M0.33M1.18M24.09M1.65M1.41M
Operating items
Research & Development 4.74M4.75M6.16M4.69M5.66M8.85M8.59M7.07M8.91M9.34M11.38M12.30M12.10M13.19M13.19M12.16M14.11M13.82M14.11M19.01M22.06M15.60M19.08M15.27M19.85M20.91M19.17M21.70M18.51M18.35M17.34M
Selling, General & Administrative 1.37M1.62M2.39M3.37M4.78M4.56M4.38M3.91M4.67M5.32M5.60M5.36M5.83M5.80M5.93M7.13M7.66M6.75M6.04M6.56M7.24M-25.80M-27.21M117.83M-37.29M70.54M-35.06M15.14M-38.25M-28.20M-29.27M
Other Operating Expenses -20.23M-16.26M-4.00M0.10M0.51M-0.51M54.72M105.00M
Operating Expenses 6.11M6.38M8.54M12.97M10.44M13.41M16.98M10.88M13.58M14.66M16.98M17.66M17.94M19.00M19.12M29.05M21.27M20.57M20.15M25.58M29.30M25.80M27.21M25.20M37.29M91.45M-15.89M36.85M-19.74M-9.85M-11.94M
Operating Income -6.11M-6.38M-8.54M-8.05M-10.44M-13.41M-16.98M-10.88M-10.58M-14.66M-16.98M-17.66M-17.94M-19.00M-19.12M-29.05M-21.27M-20.57M-20.15M-25.58M-29.30M-25.80M-27.21M-25.20M-37.29M71.10M-34.50M-35.72M-9.44M-26.23M-27.51M
EBIT -6.11M-6.38M-8.54M-8.05M-10.44M-13.41M-16.98M-10.88M-10.58M-14.66M-16.98M-17.66M-17.94M-19.00M-19.12M-29.05M-21.27M-20.57M-20.15M-25.58M-29.30M-25.80M-27.21M-25.20M-37.29M71.10M-34.50M-35.72M-9.44M-26.23M-27.51M
Non-operating items
Interest & Investment Income 0.07M0.07M0.05M0.05M0.07M0.39M0.46M0.27M0.30M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.20M0.83M0.91M1.39M1.45M1.07M1.56M1.87M1.27M1.02M0.67M0.90M
Other Non Operating Income -0.56M0.16M-0.01M0.18M0.18M0.15M-0.57M-0.16M0.19M0.23M0.41M0.19M0.21M-0.07M0.10M0.18M-0.06M-0.44M-3.76M0.12M0.20M25.16M6.33M-13.76M20.21M-1.86M-2.67M10.83M2.64M-0.68M
Non Operating Income -1.26M0.34M-0.06M-3.23M-0.43M0.15M-0.74M0.04M-0.41M-0.49M-0.47M-0.74M-0.73M-0.64M-1.05M-1.15M-0.67M-0.64M-1.45M-3.51M5.29M-29.89M24.93M6.09M-14.46M19.75M-2.18M-3.85M9.76M-0.55M-2.34M
Net income details
EBT -6.21M-6.48M-8.64M-8.24M-10.87M-13.38M-17.71M-10.84M-10.99M-15.14M-17.45M-18.40M-18.67M-19.63M-20.17M-30.20M-21.94M-21.21M-21.60M-29.09M-24.02M-55.70M-2.28M-19.10M-51.75M90.85M-36.68M-39.56M0.32M-25.70M-29.84M
Tax Provisions 0.15M0.01M0.01M0.00M0.00M0.02M0.00M-0.01M0.01M0.00M0.01M0.03M0.03M0.02M0.02M0.01M0.26M0.03M0.04M-0.03M
Profit After Tax -7.37M-6.03M-8.60M-9.36M-10.87M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-18.68M-19.64M-20.18M-30.21M-21.96M-21.21M-21.59M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.30M-25.74M-29.82M
Income from Continuing Operations -6.21M-6.48M-8.64M-8.24M-10.87M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-18.68M-19.64M-20.18M-30.21M-21.96M-21.21M-21.59M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.28M-25.74M-29.82M
Consolidated Net Income -6.21M-6.48M-8.64M-8.24M-10.87M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-18.68M-19.64M-20.18M-30.21M-21.96M-21.21M-21.59M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.28M-25.74M-29.82M
Income towards Parent Company -6.21M-6.48M-8.64M-8.24M-10.87M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-18.68M-19.64M-20.18M-30.21M-21.96M-21.21M-21.59M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.28M-25.74M-29.82M
Preferred Dividend Payments 0.74M0.75M0.76M0.76M0.59M
Net Income towards Common Stockholders -8.11M-6.80M-9.36M-12.04M-11.46M-13.38M-17.71M-10.84M-11.14M-15.14M-17.45M-18.40M-26.91M-19.64M-20.18M-35.91M-24.22M-21.21M-21.87M-29.10M-24.02M-55.71M-2.31M-19.13M-51.77M90.83M-36.70M-39.82M0.28M-25.74M-29.82M
Additional items
EPS (Basic) -17.70-14.83-20.39-26.23-6.67-1.02-1.22-0.32-0.56-0.76-0.87-0.92-1.30-0.74-0.76-1.28-0.72-0.60-0.26-0.20-0.16-0.33-0.01-0.09-7.7713.59-5.48-0.200.04-3.47-0.69
EPS (Weighted Average and Diluted) -0.92-0.76-1.28-0.72-0.60-0.26-0.20-0.16-0.33-0.01-0.09-7.7713.57-5.48-0.200.04-3.47-0.69
Shares Outstanding (Weighted Average) 0.46M0.46M0.46M0.46M1.72M13.18M14.56M11.53M20.01M20.03M20.09M20.08M20.75M26.53M26.61M25.75M33.74M35.44M83.21M63.53M145.97M168.74M196.99M177.81M6.67M6.68M6.70M201.06M6.84M7.41M43.27M
Shares Outstanding (Diluted Average) 20.08M26.61M25.75M33.74M35.44M83.21M63.53M145.97M168.74M196.99M177.81M6.67M6.69M6.70M201.06M6.87M7.41M43.27M
EBITDA -6.11M-6.38M-8.54M-8.05M-10.85M-13.45M-17.79M-10.84M-11.14M-15.14M-17.45M-18.40M-17.94M-19.00M-19.12M-29.05M-21.27M-20.57M-20.15M-25.58M-29.30M-25.80M-27.21M-25.20M-37.29M71.10M-34.50M-35.72M-9.44M-26.23M-27.51M
Interest Expenses 0.17M0.17M0.15M0.24M0.40M0.51M0.69M0.55M0.58M0.69M0.70M0.72M0.89M0.91M0.92M0.93M0.91M0.92M1.02M1.14M1.11M1.15M1.63M1.89M1.87M2.18M2.41M2.30M2.20M2.23M2.26M
Shares Outstanding 0.35M0.35M0.35M0.35M6.72M12.43M12.44M16.13M16.14M16.18M16.29M16.31M23.43M24.58M24.71M28.13M30.81M30.99M68.73M121.67M122.21M164.42M164.71M5.58M5.60M5.61M5.62M5.70M5.79M7.96M25.15M
Tax Rate -1.35-0.03-0.03-0.01-0.01-0.10-0.020.06-0.05-0.02-0.03-1.14-0.17-0.040.02-0.04-0.6510.76-0.140.10